0001579600-18-000001.txt : 20180112 0001579600-18-000001.hdr.sgml : 20180112 20180112145853 ACCESSION NUMBER: 0001579600-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180112 DATE AS OF CHANGE: 20180112 EFFECTIVENESS DATE: 20180112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: T3D Therapeutics, Inc. CENTRAL INDEX KEY: 0001579600 IRS NUMBER: 461674269 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-303178 FILM NUMBER: 18525765 BUSINESS ADDRESS: STREET 1: 1100 BEARGLADES LANE CITY: RALEIGH STATE: NC ZIP: 27615 BUSINESS PHONE: 919-949-0517 MAIL ADDRESS: STREET 1: 1100 BEARGLADES LANE CITY: RALEIGH STATE: NC ZIP: 27615 D 1 primary_doc.xml X0708 D LIVE 0001579600 T3D Therapeutics, Inc. 68 TW Alexander Drive Research Triangle Park NC NORTH CAROLINA 27709 919-237-4897 DELAWARE None None Corporation true John Didsbury 68 TW Alexander Drive Research Triangle Park NC NORTH CAROLINA 27709 Executive Officer Director Promoter Charles Lineberry 68 TW Alexander Drive Research Triangle Park NC NORTH CAROLINA 27709 Director Barry Buzogany 68 TW Alexander Drive Research Triangle Park NC NORTH CAROLINA 27709 Director John A. Golden 68 TW Alexander Drive Research Triangle Park NC NORTH CAROLINA 27709 Director Tom Mendell 68 TW Alexander Drive Research Triangle Park NC NORTH CAROLINA 27709 Director Pharmaceuticals Decline to Disclose 06b false 2018-01-05 false true true true false 0 1000000 711270 288730 false 30 0 0 0 Proceeds will be used for working capital, which may include normal compensation to executive officers. false T3D Therapeutics, Inc. John Didsbury John Didsbury President and CEO 2018-01-12